Effect of Oxcarbazepine on Serum Brain Derived Neurotrophic Factor (BDNF) in Bipolar Disorder
Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
The present study has been designed to evaluate the change in serum BDNF level with
oxcarbazepine monotherapy in bipolar disorder and to explore the possibility of its
neuroprotective effect.
Phase:
Phase 4
Details
Lead Sponsor:
All India Institute of Medical Sciences, Bhubaneswar